Proving that the vaccine works to regulators, along with short-term safety data, is the first hurdle.
This is a marathon and this is only at the first leg of the race.
Most transgender persons do not consult or seek guidance from medical professionals due to the fear of stigma and discrimination.
With shrinking national budgets, increasing deficits, demands for welfare assistance, and economies which are struggling to recover from month long lock-downs and harsh restrictive measures, investing in the unknown is a difficult decision to make.
The best chance of success for any country is to participate in an endeavour which diversifies and broadens access to a broad portfolio of possible vaccine candidates.
A select committee is much needed to provide rigorous oversight to the actions, policies, and governance of the Ministry of Health, particularly since it is the budget holder, regulator and healthcare provider.
Proposals should not come from an angry or frustrated place, and must be evidence-based.
Developing the capacity to rapidly fill vaccine vials and finish packaging vaccines for manufacturers in a public health emergency, is an issue of national security.